714
Views
6
CrossRef citations to date
0
Altmetric
Review Articles

Transporter-mediated drug–drug interactions: advancement in models, analytical tools, and regulatory perspective

ORCID Icon, ORCID Icon, , , , ORCID Icon, , ORCID Icon, & ORCID Icon show all
Pages 285-320 | Received 16 Jan 2021, Accepted 05 May 2021, Published online: 02 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hiroaki Takubo, Koji Bessho, Ryosuke Watari & Ryota Shigemi. (2022) Quantitative prediction of OATP1B-mediated drug–drug interactions using endogenous biomarker coproporphyrin I. Xenobiotica 52:4, pages 397-404.
Read now

Articles from other publishers (5)

Zhengping Hu, Wenyan Wang, Huijie Yang, Fengjuan Zhao, Chunjie Sha, Wei Mi, Shuying Yin, Hongbo Wang, Jingwei Tian & Liang Ye. (2024) Metabolism, Disposition, Excretion, and Potential Transporter Inhibition of 7–16, an Improving 5-HT2A Receptor Antagonist and Inverse Agonist for Parkinson’s Disease. Molecules 29:10, pages 2184.
Crossref
Arne Gessner, Fabian Müller, Pia Wenisch, Markus R. Heinrich, Jörg König, Peter Stopfer & Martin F. Fromm. (2023) A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter‐Mediated Drug‐Drug Interactions. Clinical Pharmacology & Therapeutics 114:5, pages 1058-1072.
Crossref
Kexin Lin, Xiaorui Kong, Xufeng Tao, Xiaohan Zhai, Linlin Lv, Deshi Dong, Shilei Yang & Yanna Zhu. (2023) Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters. Molecules 28:13, pages 5252.
Crossref
Susan Miller, Walter Moos, Barbara Munk, Stephen Munk, Charles Hart & David Spellmeyer. 2023. Managing the Drug Discovery Process. Managing the Drug Discovery Process 207 338 .
Yang Li, Zahra Talebi, Xihui Chen, Alex Sparreboom & Shuiying Hu. (2021) Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation. Molecules 26:18, pages 5500.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.